140 related articles for article (PubMed ID: 11533167)
1. Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines.
O'Hagan D; Singh M; Ugozzoli M; Wild C; Barnett S; Chen M; Schaefer M; Doe B; Otten GR; Ulmer JB
J Virol; 2001 Oct; 75(19):9037-43. PubMed ID: 11533167
[TBL] [Abstract][Full Text] [Related]
2. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles.
Denis-Mize KS; Dupuis M; Singh M; Woo C; Ugozzoli M; O'Hagan DT; Donnelly JJ; Ott G; McDonald DM
Cell Immunol; 2003 Sep; 225(1):12-20. PubMed ID: 14643300
[TBL] [Abstract][Full Text] [Related]
4. Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins.
Otten GR; Schaefer M; Doe B; Liu H; Srivastava I; Megede Jz; Kazzaz J; Lian Y; Singh M; Ugozzoli M; Montefiori D; Lewis M; Driver DA; Dubensky T; Polo JM; Donnelly J; O'Hagan DT; Barnett S; Ulmer JB
J Virol; 2005 Jul; 79(13):8189-200. PubMed ID: 15956564
[TBL] [Abstract][Full Text] [Related]
5. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
Kaneko H; Bednarek I; Wierzbicki A; Kiszka I; Dmochowski M; Wasik TJ; Kaneko Y; Kozbor D
Virology; 2000 Feb; 267(1):8-16. PubMed ID: 10648178
[TBL] [Abstract][Full Text] [Related]
6. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
[TBL] [Abstract][Full Text] [Related]
7. Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.
Wang S; Pal R; Mascola JR; Chou TH; Mboudjeka I; Shen S; Liu Q; Whitney S; Keen T; Nair BC; Kalyanaraman VS; Markham P; Lu S
Virology; 2006 Jun; 350(1):34-47. PubMed ID: 16616287
[TBL] [Abstract][Full Text] [Related]
8. Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticles.
Otten G; Schaefer M; Greer C; Calderon-Cacia M; Coit D; Kazzaz J; Medina-Selby A; Selby M; Singh M; Ugozzoli M; zur Megede J; Barnett SW; O'Hagan D; Donnelly J; Ulmer J
J Virol; 2003 May; 77(10):6087-92. PubMed ID: 12719603
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.
Denis-Mize KS; Dupuis M; MacKichan ML; Singh M; Doe B; O'Hagan D; Ulmer JB; Donnelly JJ; McDonald DM; Ott G
Gene Ther; 2000 Dec; 7(24):2105-12. PubMed ID: 11223992
[TBL] [Abstract][Full Text] [Related]
11. [A novel immunization strategy to induce strong humoral responses against HIV-1 using combined DNA, recombinant vaccinia virus and protein vaccines].
Liu C; Wang SH; Ren L; Hao YL; Zhang QC; Liu Y
Bing Du Xue Bao; 2014 Nov; 30(6):645-51. PubMed ID: 25868279
[TBL] [Abstract][Full Text] [Related]
12. A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.
Ferrantelli F; Maggiorella MT; Schiavoni I; Sernicola L; Olivieri E; Farcomeni S; Pavone-Cossut MR; Moretti S; Belli R; Collacchi B; Srivastava IK; Titti F; Cafaro A; Barnett SW; Ensoli B
Vaccine; 2011 Apr; 29(16):2918-32. PubMed ID: 21338681
[TBL] [Abstract][Full Text] [Related]
13. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.
Shata MT; Hone DM
J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.
Kazzaz J; Singh M; Ugozzoli M; Chesko J; Soenawan E; O'Hagan DT
J Control Release; 2006 Feb; 110(3):566-73. PubMed ID: 16360956
[TBL] [Abstract][Full Text] [Related]
16. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
McBurney SP; Young KR; Ross TM
Virology; 2007 Feb; 358(2):334-46. PubMed ID: 17011011
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus.
Himeno A; Akagi T; Uto T; Wang X; Baba M; Ibuki K; Matsuyama M; Horiike M; Igarashi T; Miura T; Akashi M
Vaccine; 2010 Jul; 28(32):5377-85. PubMed ID: 20472029
[TBL] [Abstract][Full Text] [Related]
18. DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.
Chikhlikar P; Barros de Arruda L; Maciel M; Silvera P; Lewis MG; August JT; Marques ET
PLoS One; 2006 Dec; 1(1):e135. PubMed ID: 17205139
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
20. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
